mRNA Vaccine and Therapeutics Market - 2026-2033

July 2026 | 55 pages | ID: M49B709168A5EN
DataM Intelligence

Abstracts

mRNA Vaccine and Therapeutics Marketis is growing with a CAGR of 18.40% during the forecast period 2026-2035.

The mRNA Vaccine and Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A mRNA Vaccine and Therapeutics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Prophylactic Vaccines*
• Therapeutic Vaccines
• Therapeutic Drugs

By Application

• Cancer*
• Infectious Diseases
• Rare Genetic Diseases
• Others

By End-user

• Hospitals & Clinics*
• Research Organization
• Academic Institutes
• Others

Regional Analysis for mRNA Vaccine and Therapeutics Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global mRNA Vaccine and Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY PRODUCT TYPE

5. SNIPPET BY APPLICATION

5.1. Snippet by End-user
5.2. Snippet by Region

6. DYNAMICS

6.1. Impacting Factors
  6.1.1. Drivers
    6.1.1.1. Growing Cases of Chronic Diseases
    6.1.1.2. Increasing Cancer Incidence
  6.1.2. Restraints
    6.1.2.1. Complications Associated with mRNA Vaccines and Therapeutics
    6.1.2.2. Data Privacy and Security Concerns
    6.1.2.3. XX
  6.1.3. Opportunity
    6.1.3.1. Rising Funding from the Government
    6.1.3.2. XX
  6.1.4. Impact Analysis

7. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

7.1. Market Leaders and Pioneers
  7.1.1. Emerging Pioneers and Prominent Players
  7.1.2. Established Leaders with Largest Marketing Brand
  7.1.3. Market Leaders with Established Products
7.2. Latest Developments and Breakthroughs
7.3. Regulatory and Reimbursement Landscape
  7.3.1. North America
  7.3.2. Europe
  7.3.3. Asia Pacific
  7.3.4. Latin America
  7.3.5. Middle East & Africa
7.4. Porter’s Five Forces Analysis
7.5. Supply Chain Analysis
7.6. Patent Analysis
7.7. SWOT Analysis
7.8. Pipeline Analysis
7.9. Epidemiology Analysis
7.10. Unmet Needs and Gaps
7.11. Recommended Strategies for Market Entry and Expansion
7.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
7.13. Pricing Analysis and Price Dynamics
7.14. Key Opinion Leaders

8. MRNA VACCINES AND THERAPEUTICS MARKET PRODUCT TYPE OUTLOOK

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  8.1.2. Market Attractiveness Index, By Product Type
8.2. Prophylactic Vaccines*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Therapeutic Vaccines
8.4. Therapeutic Drugs

9. MRNA VACCINES AND THERAPEUTICS MARKET APPLICATION OUTLOOK

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.1.2. Market Attractiveness Index, By Application
9.2. Cancer*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Infectious Diseases
9.4. Rare Genetic Diseases
9.5. Others

10. MRNA VACCINES AND THERAPEUTICS MARKET END-USER OUTLOOK

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  10.1.2. Market Attractiveness Index, By End-user
10.2. Hospitals & Clinics*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Research Organization
10.4. Academic Institutes
10.5. Others

11. MRNA VACCINES AND THERAPEUTICS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

12. INTRODUCTION

12.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.1. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

13. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRY

13.1. U.S.
  13.1.1. Canada
    13.1.1.1. Mexico
13.2. Europe
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.6.1. Germany
    13.2.6.2. UK
    13.2.6.3. France
    13.2.6.4. Spain
    13.2.6.5. Italy
    13.2.6.6. Rest of Europe
13.3. Asia-Pacific
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.6.1. China
    13.3.6.2. India
    13.3.6.3. Japan
    13.3.6.4. South Korea
    13.3.6.5. Rest of Asia-Pacific
13.4. South America
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.6.1. Brazil
    13.4.6.2. Argentina
    13.4.6.3. Rest of South America
13.5. Middle East and Africa
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking

16. COMPANY PROFILES

Key Players

1. ASTRAZENECA*

1.1. Company Overview
  1.1.1. Product Portfolio
    1.1.1.1. Product Description
    1.1.1.2. Product Key Performance Indicators (KPIs)
    1.1.1.3. Historic and Forecasted Product Sales
    1.1.1.4. Product Sales Volume

2. FINANCIAL OVERVIEW

2.1. Company Revenue
  2.1.1. Geographical Revenue Shares
    2.1.1.1. Revenue Forecasts
  2.1.2. Key Developments
    2.1.2.1. Mergers & Acquisitions
    2.1.2.2. Key Product Development Activities
    2.1.2.3. Regulatory Approvals, etc.
  2.1.3. SWOT Analysis
2.2. Pfizer Inc.
2.3. Moderna, Inc.
2.4. BioNTech SE.
2.5. Arcturus Therapeutics, Inc.
2.6. CureVac SE
2.7. Sanofi
2.8. etherna(LIST NOT EXHAUSTIVE )

3. ASSUMPTION AND RESEARCH METHODOLOGY

3.1. Data Collection Methods
3.2. Data Triangulation
3.3. Forecasting Techniques
3.4. Data Verification and Validation

4. APPENDIX

4.1. About Us and Services
4.2. Contact Us